Bench to Boardroom is a highly curated podcast for life sciences leaders who value signal over noise. Each concise episode distills the most relevant ideas, trends, and strategic insights shaping biotech, pharma, medtech, and healthcare today—always practical, always actionable. Select episodes feature distinguished guests sharing real-world perspectives from the front lines of innovation and leadership.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
27%
Guest openness
Selective
Sign up to generate a grounded pitch for Bench to Boardroom.
Signup to Generate a PitchBench to Boardroom is a highly curated podcast for life sciences leaders who value signal over noise. Each concise episode distills the most relevant ideas, trends, and strategic insights shaping biotech, pharma, medtech, and healthcare today, always practical, always actionable. Select episodes feature distinguished guests sharing real-world perspectives from the front lines of innovation and leadership.
Bench to Boardroom is hosted by Pharmaconcepts. The show has published 11 episodes to date.
Recent episodes include "The Resilient Growth Engine" (7 September 2026, 21 minutes), "The New ROI Equation" (24 August 2026, 17 minutes), and "The Cost of Delay" (3 August 2026, 11 minutes).
Bench to Boardroom publishes roughly every two weeks, with episodes averaging 11 minutes across 11 episodes.
Booking probability for Bench to Boardroom is 27%, and the host is rated Selective on guests. Bench to Boardroom requires a Pod Score of 80 or higher. Bench to Boardroom's contact route on record: public web form.
The strongest fits for Bench to Boardroom are Scientific Research & Development. Bench to Boardroom has a science audience.
Pharmaconcepts hosts Bench to Boardroom, a science podcast with 11 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #10
In this milestone tenth episode of Bench to Boardroom, we explore how life sciences companies can build a resilient growth engine capable of creating value even when geopolitics, pricing policy, regulation, capital...
Episode #9
In this episode of Bench to Boardroom, we explore why evolving regulatory, HTA, and health policy frameworks are fundamentally changing the ROI equation for biopharma investment. From EU Joint Clinical Assessment and...
Episode #8
In this episode of Bench to Boardroom, we explore why Chemistry, Manufacturing and Controls (CMC) has become one of the most underestimated determinants of commercial success in life sciences. While regulatory delays...
Episode #7
In this episode of Bench to Boardroom, we explore why the most successful life sciences leaders view health policy, regulation, and macroeconomic forces not as isolated disruptions, but as recurring cycles that shape...
Episode #6
<p>In this episode of Bench to Boardroom, we explore why the probability of success in biopharma extends far beyond the science itself. While the industry is built on evidence and innovation, investment and portfolio...
Episode #6
In this episode of Bench to Boardroom, we explore why the probability of success in biopharma extends far beyond the science itself. While the industry is built on evidence and innovation, investment and portfolio...
Episode #5
In this episode of Bench to Boardroom, we examine why so many biopharma launches fail to meet expectations despite unprecedented access to data, analytics, and technology. Using the lens of the approximately 34% of U.S...
Episode #5
<p>In this episode of Bench to Boardroom, we examine why so many biopharma launches fail to meet expectations despite unprecedented access to data, analytics, and technology. Using the lens of the approximately 34% of...
Episode #4
In this episode of Bench to Boardroom, we examine why maximizing value across a life sciences portfolio increasingly requires an asset-specific, geography-agnostic approach rather than relying on the traditional “U.S...
Episode #4
<p>In this episode of Bench to Boardroom, we examine why maximizing value across a life sciences portfolio increasingly requires an asset-specific, geography-agnostic approach rather than relying on the traditional...
Episode #3
In this episode of Bench to Boardroom, we explore why not all technology investments in life sciences are created equal — and why following the hype around AI and digital transformation may generate far weaker returns...
Episode #3
<p>In this episode of Bench to Boardroom, we explore why not all technology investments in life sciences are created equal — and why following the hype around AI and digital transformation may generate far weaker...
Episode #2
<p >Launching innovative medicines can no longer follow conventional precedent. The old formula -- U.S. first, Europe second, rest of world later -- is increasingly misaligned with the realities of today’s health...
Episode #2
Launching innovative medicines can no longer follow conventional precedent. The old formula -- U.S. first, Europe second, rest of world later -- is increasingly misaligned with the realities of today’s health policy...
Episode #1
The term Portfolio Strategy gets used constantly in life sciences. Board decks use it. Investors use it. Management teams use it. Consultants use it. But too often, portfolio strategy is treated as a static spreadsheet...
Episode #1
<p >The term Portfolio Strategy gets used constantly in life sciences. Board decks use it. Investors use it. Management teams use it. Consultants use it. But too often, portfolio strategy is treated as a static...
Bench to Boardroom
<p>Short trailer introducing the Bench to Boardroom podcast</p>
Bench to Boardroom
Short trailer introducing the Bench to Boardroom podcast
PitchCentric classifies Bench to Boardroom under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Driving the Business of Science
Executive Insights for Life Sciences Innovators
Xtalks Life Science Podcast
Biotech Talk
The BioInsights Podcast
Evaluating Biopharma
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ